Overview
Chihiro Banno practices practicing medicine in Nagoya, Japan.
Her clinical expertise encompasses Antiphospholipid Syndrome, Pelvic Inflammatory Disease, and Endometritis.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chihiro Banno
Is Chihiro Banno a top-rated expert for Antiphospholipid Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Chihiro Banno is classified as an Experienced expert for Antiphospholipid Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chihiro Banno participate in research or clinical trials?
Yes. Chihiro Banno has published 9 articles and abstracts on conditions like Antiphospholipid Syndrome. You can view a list of Chihiro Banno's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Antiphospholipid SyndromeMs. Banno isExperienced. Learn about Antiphospholipid Syndrome.
- EndometritisMs. Banno isExperienced. Learn about Endometritis.
- Pelvic Inflammatory DiseaseMs. Banno isExperienced. Learn about Pelvic Inflammatory Disease.